IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v42y2019i12d10.1007_s40264-019-00858-7.html
   My bibliography  Save this article

Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR

Author

Listed:
  • John Stekelenborg

    (Janssen R&D)

  • Johan Ellenius

    (Uppsala Monitoring Centre)

  • Simon Maskell

    (University of Liverpool
    University of Liverpool)

  • Tomas Bergvall

    (Uppsala Monitoring Centre)

  • Ola Caster

    (Uppsala Monitoring Centre)

  • Nabarun Dasgupta

    (University of North Carolina)

  • Juergen Dietrich

    (Pharmacovigilance, Bayer AG)

  • Sara Gama

    (Chief Medical Office and Patient Safety, Novartis Global Drug Development, Novartis Pharma Basel)

  • David Lewis

    (Chief Medical Office and Patient Safety, Novartis Global Drug Development, Novartis Pharma Basel
    University of Hertfordshire)

  • Victoria Newbould

    (European Medicines Agency (EMA))

  • Sabine Brosch

    (European Medicines Agency (EMA))

  • Carrie E. Pierce

    (Booz Allen Hamilton (formerly Epidemico, Inc.))

  • Gregory Powell

    (GlaxoSmithKline, Global Clinical Safety and Pharmacovigilance, RTP)

  • Alicia Ptaszyńska-Neophytou

    (Vigilance, Intelligence and Research Group, Medicines and Healthcare products Regulatory Agency (MHRA))

  • Antoni F. Z. Wiśniewski

    (AstraZeneca, Patient Safety, Office of the Chief Medical Officer, Cambridge, UK)

  • Phil Tregunno

    (Vigilance, Intelligence and Research Group, Medicines and Healthcare products Regulatory Agency (MHRA))

  • G. Niklas Norén

    (Uppsala Monitoring Centre)

  • Munir Pirmohamed

    (University of Liverpool
    Royal Liverpool and Broadgreen University Hospital NHS Trust)

Abstract

Over a period of 3 years, the European Union’s Innovative Medicines Initiative WEB-RADR project has explored the value of social media (i.e., information exchanged through the internet, typically via online social networks) for identifying adverse events as well as for safety signal detection. Many patients and clinicians have taken to social media to discuss their positive and negative experiences of medications, creating a source of publicly available information that has the potential to provide insights into medicinal product safety concerns. The WEB-RADR project has developed a collaborative English language workspace for visualising and analysing social media data for a number of medicinal products. Further, novel text and data mining methods for social media analysis have been developed and evaluated. From this original research, several recommendations are presented with supporting rationale and consideration of the limitations. Recommendations for further research that extend beyond the scope of the current project are also presented.

Suggested Citation

  • John Stekelenborg & Johan Ellenius & Simon Maskell & Tomas Bergvall & Ola Caster & Nabarun Dasgupta & Juergen Dietrich & Sara Gama & David Lewis & Victoria Newbould & Sabine Brosch & Carrie E. Pierce , 2019. "Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR," Drug Safety, Springer, vol. 42(12), pages 1393-1407, December.
    • Handle: RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00858-7
    DOI: 10.1007/s40264-019-00858-7
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-019-00858-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-019-00858-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Bissan Audeh & Florelle Bellet & Marie-Noëlle Beyens & Agnès Lillo-Le Louët & Cédric Bousquet, 2020. "Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project," Drug Safety, Springer, vol. 43(9), pages 835-851, September.
    2. Andrew Bate & Steve F. Hobbiger, 2021. "Artificial Intelligence, Real-World Automation and the Safety of Medicines," Drug Safety, Springer, vol. 44(2), pages 125-132, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00858-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.